Comparing effects of GLP-1 receptor drugs, metformin, and inositol on body measurements and metabolism in women with polycystic ovary syndrome

Polycystic Ovary Syndrome (PCOS) is associated with obesity, insulin resistance, and cardiometabolic risks.

• Lifestyle intervention is considered the first-line therapy for managing PCOS.
• Drug therapies may be necessary for effective treatment.
• Common medications include metformin, myoinositol, and GLP-1 receptor agonists.
• The comparative metabolic efficacy of these treatments is not well established.

Simplified